LETTER TO THE EDITOR Subcutaneous (SC) Methotrexate (MTX) is Better and Well-Tolerable than Oral MTX in Rheumatoid Arthritis Patients, Switched from Oral to SC Administration Due to Gastrointestinal Side Effects



Pinar Borman1, *, Gülseren Demir 2, Ferda Kaygısız 2, Muyesser Okumuş 2
1 University of Hacettepe Faculty of Medicine, Dept of Physical Medicine and Rehabilitation, Sihhiye, Ankara, Turkey
2 Ankara Training and Research Hospital, Clinic of Physical Medicine and Rehabilitation, Cebeci, Ankara, Turkey


Article Metrics

CrossRef Citations:
3
Total Statistics:

Full-Text HTML Views: 492
Abstract HTML Views: 294
PDF Downloads: 122
Total Views/Downloads: 908
Unique Statistics:

Full-Text HTML Views: 267
Abstract HTML Views: 182
PDF Downloads: 86
Total Views/Downloads: 535



© Borman et al.; Licensee Bentham Open.

open-access license: This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.

* Address correspondence to this author at the University of Hacettepe Faculty of Medicine, Dept of Physical Medicine and Rehabilitation, Sihhiye, Ankara, Turkey; Tel: 905324649897; Fax: 903123105769; E-mail: pinarborman@gmail.com